FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent On Novel Formulations of Palmitoylethanolamide, Presents Preclinical Toxicology Results at an International Symposium  https://t.co/XNI798Pqy2  https://t.co/XCcaoNrfH4